Sylvie Retout

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Emergency Department

Coronary Artery

Inflammatory Response

Top Venues

Clinical and translational science

Clinical pharmacokinetics

CPT: pharmacometrics & systems pharmacology

Journal of pharmacokinetics and pharmacodynamics

This page only lists publications with an associated author ORCID identifier.

Publications

Qiudi Jiang, Yuchen Zhang, Dan Duan, Sylvie Retout, Ruchi Upmanyu, Katerina Glavini, Miriam Triyatni, Yonghong Zhu, Joseph F Grippo, Yuyan Jin
Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu-like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll-like receptor 7 agonist ruzotolimod. Clinical and translational science 17 (8) (2024)
Morgane Philipp, Simon Buatois, Sylvie Retout, France Mentré
Impact of covariate model building methods on their clinical relevance evaluation in population pharmacokinetic analyses: comparison of the full model, stepwise covariate model (SCM) and SCM+ approaches. Journal of pharmacokinetics and pharmacodynamics (2024)
Zrinka Duvnjak, Franziska Schaedeli Stark, Valérie Cosson, Sylvie Retout, Emilie Schindler, João A Abrantes
Simulation-based evaluation of the Pharmpy Automatic Model Development tool for population pharmacokinetic modeling in early clinical drug development. CPT: pharmacometrics & systems pharmacology (2024)
Qiudi Jiang, Yuchen Zhang, Dan Duan, Sylvie Retout, Ruchi Upmanyu, Katerina Glavini, Miriam Triyatni, Yonghong Zhu, Joseph F Grippo, Yuyan Jin
Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu-like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll-like receptor 7 agonist ruzotolimod. Clinical and translational science 17 (8) (2024)
Sylvie Retout, Stefan De Buck, Sébastien Jolivet, Vincent Duval, Valérie Cosson
A Pharmacokinetics-Time to Alleviation of Symptoms Model to Support Extrapolation of Baloxavir Marboxil Clinical Efficacy in Different Ethnic Groups with Influenza A or B. Clinical pharmacology and therapeutics 112 (2) (2022)
Sylvie Retout, Christophe Schmitt, Claire Petry, François Mercier, Nicolas Frey
Population Pharmacokinetic Analysis and Exploratory Exposure-Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A. Clinical pharmacokinetics 59 (12) (2021)
Fredrik Jonsson, Christophe Schmitt, Claire Petry, Francois Mercier, Nicolas Frey, Sylvie Retout
Exposure-Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII. Clinical pharmacokinetics 60 (7) (2021)